GO:0034146 toll-like receptor 5 signaling pathway: Bacterial Flagellin Sensing, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0034146 describes the molecular signaling cascade triggered when a ligand, canonically bacterial flagellin, binds to toll-like receptor 5 (TLR5).
• TLR5 is a pattern-recognition receptor of the innate immune system that detects flagellated bacteria and initiates inflammatory and antimicrobial responses.
• TLR5 signaling proceeds through the MyD88-dependent adaptor pathway, leading to NF-kB and MAPK activation and pro-inflammatory cytokine production.
• Beyond host defense, TLR5 signaling influences liver regeneration, hepatotoxicity, fibrosis, intestinal barrier function, and antibiotic resistance during superinfection.
• Dysregulated TLR5 signaling is implicated in inflammatory, infectious, and metabolic liver diseases, making it a target for experimental therapeutics.
• CRISPR-based knockout, knock-in, and overexpression models are essential tools for dissecting TLR5 pathway gene function in vitro and in vivo.
Description
Toll-like receptor 5 (TLR5) is a member of the toll-like receptor family that recognizes bacterial flagellin, a structural protein of motile bacteria. The signaling cascade initiated by flagellin binding to TLR5 is annotated as GO:0034146, toll-like receptor 5 signaling pathway, a biological process that couples microbial detection to innate immune activation. This pathway is conserved in mammals and is critical for sensing flagellated pathogens at mucosal surfaces and in systemic compartments. Research on GO:0034146 has expanded beyond classical infection biology. Studies in mouse models have shown that TLR5-mediated signaling enhances liver regeneration after partial hepatectomy, mitigates acetaminophen-induced hepatotoxicity, and ameliorates liver fibrosis through interferon beta-modulated IL-1 receptor antagonist induction. In the intestine, epithelial TLR5 signaling promotes barrier-supportive macrophages, linking flagellin sensing to mucosal homeostasis. Additionally, triggering TLR5 signaling during pneumococcal superinfection prevents the selection of antibiotic resistance, highlighting a role in host-pathogen-antibiotic interactions. For researchers, GO:0034146 provides a defined framework to study how a single receptor-ligand interaction reprograms cellular transcription, cytokine secretion, and tissue repair. Understanding its molecular components, regulatory checkpoints, and disease associations is essential for developing TLR5-targeted interventions and for interpreting innate immune phenotypes in CRISPR-edited models.
toll-like receptor 5 signaling pathway At A Glance
| GO ID | GO:0034146 |
|---|---|
| GO term | toll-like receptor 5 signaling pathway |
| Ontology | biological_process |
| Synonym | TLR5 signaling pathway; toll-like receptor 5 signalling pathway |
| Definition | The series of molecular signals initiated by a ligand binding to toll-like receptor 5. |
| Major function | Detection of bacterial flagellin and initiation of innate immune and inflammatory responses. |
| Key receptor | TLR5 (toll-like receptor 5). |
| Canonical ligand | Bacterial flagellin. |
| Primary adaptor | MyD88 (myeloid differentiation primary response 88). |
| Downstream effectors | NF-kB, MAPK, and pro-inflammatory cytokines. |
What Is GO:0034146?
GO:0034146, toll-like receptor 5 signaling pathway, is defined as the series of molecular signals initiated by a ligand binding to toll-like receptor 5. In practice, this includes flagellin recognition by TLR5, recruitment of adaptor proteins such as MyD88, activation of downstream kinases and transcription factors, and the resulting cellular responses.
Why Is toll-like receptor 5 signaling pathway Important in Cell Biology?
GO:0034146 is important because it defines how the innate immune system converts detection of bacterial flagellin into protective and sometimes pathological responses. TLR5 signaling is a first-line defense against flagellated pathogens, but its dysregulation contributes to inflammatory liver injury, fibrosis, and impaired mucosal immunity. Understanding this pathway also informs antibiotic stewardship, as TLR5 activation can reduce the emergence of antibiotic-resistant pneumococci during superinfection.
• TLR5 is a pattern-recognition receptor that detects bacterial flagellin and initiates innate immune signaling.
• The pathway activates NF-kB and MAPK cascades, driving pro-inflammatory cytokine and chemokine production.
• TLR5 signaling enhances liver regeneration after injury in mouse models.
• Exogenous TLR5 activation mitigates acetaminophen-induced hepatotoxicity.
• TLR5 signaling ameliorates liver fibrosis via interferon beta and IL-1 receptor antagonist.
• Intestinal epithelial TLR5 signaling promotes barrier-supportive macrophages.
• Triggering TLR5 during pneumococcal superinfection prevents selection of antibiotic resistance.
• Dysregulated TLR5 responses are linked to inflammatory and infectious disease pathology.
• TLR5 pathway genes are tractable targets for CRISPR knockout, knock-in, and overexpression studies.
• The pathway connects microbial sensing to tissue repair, metabolism, and host defense.
What Happens During toll-like receptor 5 signaling pathway?
Ligand recognition by TLR5
In simple terms: TLR5 acts like a sentinel that spots a specific bacterial protein called flagellin.
The pathway begins when bacterial flagellin binds to the extracellular domain of TLR5, a member of the toll-like receptor family. This recognition event is the initiating step defined by GO:0034146. TLR5 is expressed on various cell types, including epithelial cells and immune cells, allowing detection of flagellated bacteria at mucosal surfaces and in systemic compartments.
Adaptor recruitment and MyD88-dependent signaling
In simple terms: Once TLR5 grabs flagellin, it recruits a relay protein called MyD88 to pass the signal inside the cell.
Ligand-bound TLR5 recruits the adaptor protein MyD88, a central node in toll-like receptor signaling. MyD88 nucleates a signaling complex that activates downstream kinases, including IRAK family members and TRAF6, which propagate the signal toward transcription factor activation. This MyD88-dependent arm is the canonical route for TLR5 signaling.
Activation of NF-kB and MAPK pathways
In simple terms: The signal flips switches called NF-kB and MAPK that turn on immune response genes.
Downstream of MyD88, the pathway activates NF-kB and mitogen-activated protein kinase (MAPK) cascades. These transcription factors induce expression of pro-inflammatory cytokines, chemokines, and antimicrobial effectors. In intestinal epithelium, TLR5 signaling promotes barrier-supportive macrophages, indicating cell-type-specific transcriptional outcomes.
Tissue-specific outcomes: liver regeneration and hepatoprotection
In simple terms: In the liver, TLR5 signaling can help the organ regrow and protect it from damage.
TLR5-mediated signaling enhances liver regeneration in mice after partial hepatectomy. Exogenous activation of TLR5 signaling mitigates acetaminophen-induced hepatotoxicity. Additionally, TLR5 signaling ameliorates liver fibrosis by inducing interferon beta-modulated IL-1 receptor antagonist. These findings show that GO:0034146 extends beyond infection to tissue repair and protection.
Modulation of antibiotic resistance during superinfection
In simple terms: Turning on TLR5 during a secondary infection can stop antibiotic-resistant bacteria from taking over.
Triggering TLR5 signaling during pneumococcal superinfection prevents the selection of antibiotic resistance. This indicates that the pathway can shape host-pathogen dynamics and treatment outcomes, linking innate immune activation to antimicrobial stewardship.
Key Genes Involved in GO:0034146 toll-like receptor 5 signaling pathway
The following genes and proteins are central to the initiation, propagation, and regulation of GO:0034146, toll-like receptor 5 signaling pathway.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TLR5 | Pattern-recognition receptor for bacterial flagellin; initiates the pathway | Core receptor for knockout, knock-in, and overexpression studies |
| MYD88 | Adaptor protein recruited by TLR5; nucleates downstream signaling | Key node for loss-of-function and point-mutation analysis |
| TRAF6 | E3 ubiquitin ligase that propagates MyD88-dependent signaling | Target for studying ubiquitination and NF-kB activation |
| IRAK4 | Kinase that acts downstream of MyD88 in TLR signaling | Candidate for kinase-dead and knock-in models |
| IRAK1 | Kinase involved in TLR5 signal transduction | Used in epistasis and phosphorylation studies |
| NFKB1 | Transcription factor subunit activated by TLR5 signaling | Reporter and knockout models for inflammatory output |
| MAPK1 | Mitogen-activated protein kinase downstream of TLR5 | Readout for MAPK cascade activation |
| MAPK3 | Mitogen-activated protein kinase downstream of TLR5 | Readout for MAPK cascade activation |
| IFNB1 | Interferon beta induced in TLR5-mediated liver fibrosis amelioration | Target for cytokine profiling and knock-in reporters |
| IL1RN | IL-1 receptor antagonist induced via interferon beta in TLR5 signaling | Biomarker and therapeutic candidate |
| MUC2 | Mucin secreted by goblet cells in sentinel responses linked to innate sensing | Readout for mucosal barrier studies |
| NLRC4 | Inflammasome sensor in related innate immune pathways | Context for cross-talk with TLR5 signaling |
| NLRP6 | Inflammasome component in goblet cell sentinel function | Model for mucosal innate immunity interactions |
| CXCL1 | Chemokine induced by TLR5-driven inflammation | Readout for neutrophil recruitment |
| IL6 | Pro-inflammatory cytokine induced by TLR5 signaling | Common readout for pathway activation |
| TNF | Pro-inflammatory cytokine induced by TLR5 signaling | Common readout for pathway activation |
| RELA | NF-kB subunit activated downstream of TLR5 | Reporter and knockout studies |
How Is toll-like receptor 5 signaling pathway Regulated?
TLR5 signaling is regulated at multiple levels. The pathway is initiated by flagellin binding and proceeds through MyD88-dependent adaptor recruitment. Negative regulation occurs through degradation of signaling intermediates and feedback inhibition of NF-kB and MAPK cascades. Tissue-specific modulation is evident in the liver, where interferon beta and IL-1 receptor antagonist mediate the anti-fibrotic effects of TLR5 signaling. Intestinal epithelial TLR5 signaling is also modulated by the mucosal microenvironment, influencing macrophage phenotypes that support barrier function.
toll-like receptor 5 signaling pathway and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TLR5 | Liver injury and fibrosis | Tlr5 knockout mice with acetaminophen or CCl4 treatment |
| TLR5 | Liver regeneration | Partial hepatectomy in Tlr5 knockout mice |
| TLR5 | Pneumococcal superinfection and antibiotic resistance | Mouse superinfection models with TLR5 agonist |
| TLR5 | Intestinal barrier dysfunction | Intestinal epithelial-specific Tlr5 knockout mice |
| MYD88 | Innate immune signaling defects | Myd88 knockout macrophages and epithelial cells |
Liver injury and fibrosis
TLR5 signaling protects against acetaminophen-induced hepatotoxicity and ameliorates liver fibrosis by inducing interferon beta-modulated IL-1 receptor antagonist. These findings position GO:0034146 as a modifier of drug-induced liver injury and fibrotic progression.
Liver regeneration
TLR5-mediated signaling enhances liver regeneration in mice, linking innate immune sensing to hepatocyte proliferation after partial hepatectomy. This suggests that TLR5 pathway activity may influence recovery after surgical or toxic liver injury.
Intestinal barrier and mucosal immunity
Intestinal epithelial TLR5 signaling promotes barrier-supportive macrophages, contributing to mucosal homeostasis. Disruption of this pathway could impair barrier function and increase susceptibility to flagellated pathogens.
Antibiotic resistance in superinfection
Triggering TLR5 signaling during pneumococcal superinfection prevents the selection of antibiotic resistance, indicating that innate immune activation can alter evolutionary outcomes in bacterial populations.
From toll-like receptor 5 signaling pathway-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does TLR5 loss alter liver regeneration? | TLR5 knockout mouse or hepatocyte-specific knockout |
| Can TLR5 activation protect against hepatotoxicity? | TLR5 agonist treatment in wild-type and knockout mice |
| What is the role of TLR5 in intestinal barrier function? | Intestinal epithelial-specific TLR5 knockout |
| Does TLR5 signaling prevent antibiotic resistance? | TLR5 agonist in pneumococcal superinfection model |
| How does TLR5 signaling ameliorate fibrosis? | TLR5 knockout with fibrosis induction and interferon beta readout |
| Which downstream genes require MyD88? | MyD88 knockout cells with TLR5 stimulation |
How to Study the toll-like receptor 5 signaling pathway Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global transcriptional changes after TLR5 activation | Identify NF-kB and MAPK target genes |
| ELISA/multiplex | Cytokine and chemokine secretion | Quantify IL-6, TNF, CXCL1, IFN-beta |
| Western blot | Phosphorylation of MAPK and NF-kB subunits | Confirm pathway activation |
| Reporter assays | NF-kB or interferon-responsive promoter activity | Screen TLR5 signaling modulators |
| Partial hepatectomy | Liver regeneration kinetics | Test TLR5 role in regeneration |
| Acetaminophen challenge | Hepatotoxicity markers | Evaluate TLR5-mediated protection |
| Fibrosis induction | Collagen deposition and IL-1RA expression | Study TLR5 anti-fibrotic effects |
| Superinfection model | Antibiotic resistance emergence | Test TLR5 agonist effects |
Transcriptomic profiling of TLR5 activation
RNA sequencing after flagellin stimulation of wild-type and TLR5-knockout cells can identify NF-kB and MAPK target genes induced by GO:0034146. This approach reveals cell-type-specific responses, such as those in intestinal epithelium.
Cytokine and chemokine measurement
ELISA and multiplex assays quantify IL-6, TNF, CXCL1, and interferon beta produced downstream of TLR5 signaling. These readouts are used to assess pathway activity in liver and immune models.
In vivo liver injury and regeneration models
Partial hepatectomy and acetaminophen or CCl4 challenge in mice are established models to study TLR5 effects on regeneration, hepatotoxicity, and fibrosis.
Microbiome and infection models
Pneumococcal superinfection models and intestinal epithelial knockout mice allow assessment of TLR5 signaling in host-pathogen interactions and barrier function.
How CRISPR Can Be Used to Study GO:0034146 toll-like receptor 5 signaling pathway
Knockout
CRISPR knockout of TLR5 or MYD88 in cell lines and mice abolishes flagellin-induced signaling, enabling identification of genes strictly dependent on GO:0034146. Knockout models are used to test liver regeneration, hepatotoxicity, and intestinal barrier phenotypes.
Point Mutation
Point mutations in TLR5 or downstream kinases can dissect domain-specific functions, such as ligand-binding residues or phosphorylation sites required for MyD88 recruitment. These models help distinguish signaling branches without fully deleting the gene.
Knock-in
Knock-in of tagged TLR5 or reporter alleles allows visualization and purification of pathway components in vivo. Knock-in of disease-associated variants can test their impact on NF-kB and MAPK activation.
Overexpression
Overexpression of TLR5 or constitutively active downstream effectors amplifies pathway output and can model chronic inflammation or tissue protection observed in liver and intestinal studies.
How EDITGENE Supports toll-like receptor 5 signaling pathway Research
Researchers studying toll-like receptor 5 signaling pathway-related genes often need to determine whether a candidate gene is causally involved in flagellin sensing, NF-kB activation, or tissue-specific outcomes such as liver regeneration and barrier protection. CRISPR-based models provide the precision required to move from correlation to causation.
Contact EDITGENE today to design your custom CRISPR model for toll-like receptor 5 signaling pathway research.
Frequently Asked Questions About toll-like receptor 5 signaling pathway
What is toll-like receptor 5 signaling pathway?
It is the series of molecular signals initiated by a ligand binding to toll-like receptor 5, annotated as GO:0034146.
What genes are involved in toll-like receptor 5 signaling pathway?
Key genes include TLR5, MYD88, TRAF6, IRAK4, IRAK1, NFKB1, MAPK1, MAPK3, IFNB1, and IL1RN.
What is the ligand for TLR5?
Bacterial flagellin is the canonical ligand that binds TLR5 and initiates the pathway.
What does TLR5 signaling do in the liver?
It enhances liver regeneration, mitigates acetaminophen-induced hepatotoxicity, and ameliorates fibrosis via interferon beta and IL-1 receptor antagonist.
How does TLR5 signaling affect the intestine?
Intestinal epithelial TLR5 signaling promotes barrier-supportive macrophages and contributes to mucosal homeostasis.
Can TLR5 signaling influence antibiotic resistance?
Yes, triggering TLR5 signaling during pneumococcal superinfection prevents the selection of antibiotic resistance.
What adaptor protein does TLR5 use?
TLR5 signals through the MyD88-dependent adaptor pathway.
What transcription factors are activated by TLR5?
NF-kB and MAPK cascades are activated downstream of TLR5 signaling.
How can I study TLR5 signaling with CRISPR?
Knockout, point mutation, knock-in, and overexpression models can be used to dissect pathway components and outcomes.
What diseases are linked to TLR5 signaling?
Liver injury, fibrosis, impaired intestinal barrier function, and infectious complications with antibiotic resistance have been linked to TLR5 signaling.
Conclusion
GO:0034146, toll-like receptor 5 signaling pathway, is a central innate immune cascade that translates flagellin detection into inflammatory, antimicrobial, and tissue-protective responses. Its roles in liver regeneration, hepatotoxicity, fibrosis, intestinal barrier function, and antibiotic resistance highlight its broad physiological and pathological importance. CRISPR-based knockout, point mutation, knock-in, and overexpression models are powerful tools for dissecting the molecular logic of this pathway. EDITGENE provides end-to-end services to generate and analyze these models, accelerating discovery in TLR5 biology and therapeutic development.
References
- 1. Zhang W et al.. 2021. Toll-like receptor 5-mediated signaling enhances liver regeneration in mice.. Mil Med Res 8(1):16 PMID: 33622404
- 2. Takeda K et al.. 2003. Toll-like receptors.. Annu Rev Immunol 21:335-76 PMID: 12524386
- 3. Costa C et al.. 2024. Triggering Toll-Like Receptor 5 Signaling During Pneumococcal Superinfection Prevents the Selection of Antibiotic Resistance.. J Infect Dis 230(5):e1126-e1135 PMID: 38716762
- 4. Zhou Z et al.. 2021. Exogenous activation of toll-like receptor 5 signaling mitigates acetaminophen-induced hepatotoxicity in mice.. Toxicol Lett 342:58-72 PMID: 33571619
- 5. Tsai MT et al.. 2026. Intestinal epithelial TLR5 signaling promotes barrier-supportive macrophages.. Sci Immunol 11(115):eadr4057 PMID: 41544147
- 6. Muzio M et al.. 2000. Toll-like receptor family and signalling pathway.. Biochem Soc Trans 28(5):563-6 PMID: 11044375
- 7. Birchenough GM et al.. 2016. A sentinel goblet cell guards the colonic crypt by triggering Nlrp6-dependent Muc2 secretion.. Science 352(6293):1535-42 PMID: 27339979
- 8. Zhou Z et al.. 2020. Toll-Like Receptor 5 Signaling Ameliorates Liver Fibrosis by Inducing Interferon β-Modulated IL-1 Receptor Antagonist in Mice.. Am J Pathol 190(3):614-629 PMID: 31972159
